Latest ResMed News & Updates

See the latest news and media coverage for ResMed. We track all announcements, press releases, and industry mentions in real time, all in one place.

ResMed

Medical technology company for sleep and respiratory care

resmed.com

Headquarters: San Diego, United States
Company type: Public company
Number of employees: 9,200–10,000
Industry: Medical Equipment, Supplies & Distribution

Last updated October 30

Latest news about ResMed

In short: ResMed reported strong fiscal 2026 earnings, completed the Noctrix acquisition, sold MatrixCare, and appointed a new CFO.

Company announcements

October 29 ResMed

ResMed reports first quarter fiscal year 2027 financial results

ResMed posted $1.4B revenue and $2.92 EPS, divested MatrixCare, launched AirTouch F40, and returned over $1B to shareholders via dividends and buybacks.

August 7 ResMed

ResMed reports Q4 fiscal 2026 revenue of $1.5 billion

Fiscal 2026 full-year revenue reached $5.7 billion with 17% non-GAAP EPS growth and $1 billion in shareholder returns

June 30 ResMed

ResMed sets date for Q4 fiscal 2026 earnings report

The results will be released after market close, followed by a management webcast.

April 30 ResMed

ResMed announces Q3 FY2026 results

Revenue rises 11% to $1.4B. GAAP EPS hits $2.74; non-GAAP $2.86. Gross margin expands 290 bps. Cash flow reaches $554M.

Media coverage

October 30 MSN

ResMed Inc. reports Q1 fiscal year 2027 revenue of $1.4 billion and declares quarterly cash dividend of $0.66 per share

ResMed Inc. announced its financial results for the first quarter of fiscal year 2027 ended September 30, 2026. The company reported that Q1 revenue increased...

October 29 RTTNews

Resmed Inc Q1 Income Advances

Resmed Inc (RMD.AX) released a profit for its first quarter that Increases, from last year The company's bottom line totaled $418.413 million, or $2.92 per...

October 28 Capital Brief

Resmed shares open higher as Q1 revenue gains 6% to $2b

Medical equipment business Resmed has seen its first quarter revenue lift 6% to USD1.4 billion ($1.99 billion) amid higher ...

August 10 Medical Device Network

Resmed's stock falls by 7% on soft FY27 outlook

Resmed highlighted that factors including suspended ventilator sales and ongoing macro uncertainty had contributed to its tempered FY27 outlook.

Never miss news about ResMed

Track ResMed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.